MedPath

Clinical Trial of Ultrasound Combined With Computed Tomography Guided Lumbar Sympathetic Ganglion Block

Not Applicable
Conditions
Pain, Chronic
Ultrasound Therapy
Sympathetic Disorder
Registration Number
NCT04167956
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

To evaluate the safety and efficacy of ultrasound combined with CT-guided sympathetic ganglion block for refractory pain caused by sympathetic neuropathy of the lower extremities.

Detailed Description

To evaluate the safety and efficacy of ultrasound combined with CT-guided sympathetic ganglion block for refractory pain caused by sympathetic neuropathy of the lower extremities. Patients with lumbar sympathetic block were enrolled and randomized to a conventional CT-guided group and an ultrasound-guided CT-guided group. By comparing the traditional CT guided and ultrasound combined with CT guided two programs, the radiation dose, block success rate, treatment time, etc. received by patients with lumbar sympathetic block were observed to understand whether ultrasound combined with CT guidance is a way to reduce radiation exposure. Under the premise of the dose, the method of blocking the success rate can still be guaranteed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
246
Inclusion Criteria

1.18~80 years old; 2.Pain disorders requiring lumbar sympathetic block(Such as,Lower limb vascular disfunction,Diabetic polyneuropathy,Postherpetic neuralgia,Complex regional pain syndrome I and II,Cancer related neuropathic pain including Peripheral neuropathy caused by chemotherapy or other lower extremity sympathetic neuropathy),conservative treatment for 3 months or longer can not be cured; 3.Numerical rating score≥4.

Exclusion Criteria
  1. Body mass index> 30 kg / m2;
  2. History of internal fixation in posterior lumbar laminectomy or any serious anatomic variation, such as scoliosis and tumors;
  3. History of lumbar sympathetic neurochemistry or thermal neurolysis;
  4. Pregnancy;
  5. The puncture site is infected;
  6. Coagulation dysfunction;
  7. Allergic to local anesthetic or contrast agent;
  8. Cognitive impairment or inability to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The success rate of blockthrough study completion, an average of 7 days

Numerical rating score(NRS) less than 4

Secondary Outcome Measures
NameTimeMethod
The skin temperature10 minutes

The skin temperature

The number of patients satisfied with the first angiographyimmediately

The number of patients satisfied with the first angiography

The toe perfusion index10 minutes

The toe perfusion index

Trial Locations

Locations (1)

The second affiliated hospital of Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

The second affiliated hospital of Zhejiang University
🇨🇳Hangzhou, Zhejiang, China
Min Yan, Doctor
Contact
13757118632
zryanmin@zju.edu.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.